North Dallas Research Associates
North Dallas Research Associates is pleased to play an active role in clinical research by conducting FDA approved pharmaceutical studies in a broad range of therapeutic areas for many industry-leading pharmaceutical companies and clinical research organizations. We have made this website available in order to provide information about our current studies, our new research facility as well as our history and experience in clinical research.
Clinical Trial News
- Cardiogenesis Comments On The STAR-Heart Study Presented At European Society Of Cardiology (ESC) 2010 Congress
- Long Term Data Presented At ESC 2010 Further Support The Benefit Of The CYPHER(R) Sirolimus Drug-Eluting Stent
- Double-Dose Clopidogrel Reduces Risk Of Death, Heart Attack Or Stroke In Patients Undergoing Angioplasty
- BRINAVESS™ (vernakalant) For Infusion Approved In The European Union For Rapid Conversion Of Recent Onset Atrial Fibrillation
- New Online Health Test Helps Hispanics Cut Risk Of Heart Disease, Stroke
Interested in Signing Up for a Study?
We are regularly looking for participants for current and upcoming studies.